Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-3.97 Mil
% of Total Estimate Gain
-35.28%

Columbia Mid Cap Index Fund's Arrowhead Pharmaceuticals Inc Holding Summary

As of 2025-02-28, COLUMBIA FUNDS SERIES TRUST held - shares of Arrowhead Pharmaceuticals Inc(ARWR), totaling N/A. This investment constitutes 0% of their stock portfolio, and COLUMBIA FUNDS SERIES TRUST now holds 0% of the outstanding Arrowhead Pharmaceuticals Inc(ARWR) stock.

The initial trade took place in 2020Q1. And since then Columbia Mid Cap Index Fund has made 5 purchases of ARWR, at an average price of $51.94, for a total of 216,481.00 shares. In addition, there have been 16 sales at an average price of $33.61 for 216,481.00 shares. Based on historical transaction data and ARWR's current price of $15.96, Columbia Mid Cap Index Fund's estimated gain on his ARWR holdings is $-3.97 Mil, reflecting a -35.28% gain to date.

Columbia Mid Cap Index Fund ARWR ($15.96) Holding Chart

Columbia Mid Cap Index Fund ARWR ($15.96) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1